For the cohort in which treatment began 4 weeks after tumor inoculation, [64Cu]Cu-SARTATE PET/CT imaging of selected mice from each treatment group was carried out in week 3 and confirmed SSTR2-positive NB tumors (Additional file 1: Fig. S5). This evidence concerns the gene SSTR2 and neuroblastoma.